Here's why a gene therapy product originally developed at CHOP spinout Spark Therapeutics was shelved by Pfizer.
US pharma giant Pfizer has ended all development and commercialization activities relating to fidanacogene elaparvovec, a ...
The partners will test Summit’s ivonescimab alongside Pfizer’s antibody-drug conjugates in hopes of finding “potentially ...
Cavazzoni stepped down from her role as head of the FDA’s main drug review office in mid-January. She will succeed Aida ...
GSK is trying to bring its vaccine to market ahead of a rival jab from Pfizer, which is also anticipating regulatory approvals next year in both older adults and expectant mothers. Its vaccine is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback